The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 521-524

  Tsai, Wen Chin ^a   Pei, Dee ^a   Wang, Tso Fu ^a   Wu, Du An ^a   Li, Jer Chuan ^a   Wei, Cheng Lian ^b   Lee, Chien Hsing ^b   Chen, Sheng Pyng ^c   Kuo, Shi Wen ^a,d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Armed Forces Sung Shan Hospital   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; GLUCURONIDE; LIOTHYRONINE; PROPYLTHIOURACIL; SULFATE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; BLOATING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ENTEROHEPATIC CIRCULATION; FEMALE; FLATULENCE; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; LIVER METABOLISM; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROID FUNCTION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; CHOLESTYRAMINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRAVES DISEASE; HUMANS; ION EXCHANGE RESINS; MALE; MIDDLE AGED; PROPRANOLOL; PROPYLTHIOURACIL; RECEPTORS, THYROID HORMONE; THYROID FUNCTION TESTS; THYROXINE; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 18444371460     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02249.x     Document Type: Article

References (19)

1. Solomon, B.L., Wartofsky, L. & Burman, K.D. (1993) Adjunctive cholestyramine therapy for thyrotoxicosis. Clinical Endocrinology, 38, 39-43.
2. Haynes, R.C. Jr (1990) Thyroid and antithyroid drugs. In: Gilman, A.G., Rall, T.W., Nies, A.S. & Taylor, P., eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. Pergamon, New York, 1361-1383.
3. Bergman, F., Heedman, P. & van der Linden, W. (1996) Influence of cholestyramine on absorption and excretion thyroxine in Syrian hamster. Acta Endocrinologica, 53, 256-263.
4. Northcut, R.C., Sticl, J.N., Hollifield, J.W. & Stant, E.G. (1969) The influence of cholestyramine on thyroxine absorption. Journal of the American Medical Association, 208, 1857-1861.
5. Bergen, S.S. Jr (1959) Effect of an anion exchange resin on serum cholesterol in man. Proceedings of the Society for the Experimental Biology and Medicine, 102, 696-697.
6. Fallon, H.J. & Woods, J.W. (1968) Response of hyperlipoproteinemia to cholestyramine resin. Journal of the American Medical Association, 204, 1161-1164.
7. Mercardo, M., Mendoza-zubieta, V., Bautista-osorio, R. & Espinoza-de los Monteros, A.L. (1996) Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. Journal of Clinical Endocrinology and Metabolism, 81, 3191-3193.
8. 4-14C and its degradation products in a hypercholesterolemic patient. Journal of Clinical Investigation, 47, 1664-1671.
9. Gallo, D.C., Bailey, K.R. & Sheffner, A.L. (1965) The interaction between cholestyramine and drugs. Proceedings of the Society for the Experimental Biology and Medicine, 120, 60-65.
10. Harmon, S.M. & Seifert, C.F. (1991) Levothyroxine-cholestyramine interaction reemphasized. Annals of the International Medicine, 115, 658-659.
11. Witztum, J.L., Jacobs, L.S. & Schonfeld, G. (1978) Thyroid hormone and thyrotropin levels in patients placed on colestipol. Journal of Clinical Endocrinology and Metabolism, 46, 838-840.
12. Chopra, I.J. (1991) Nature, sources and relative biologic significance of circulating thyroid hormone. In: Braverman, L.E. & Utiger, R.D., eds. The Thyroid, a Clinical and Fundmental Text. Lippincott Williams & Wilkins, Philadelphia, 126-143.
13. Davies, T.F., Roti, E., Braverman, L.E. & DeGroot, L.J. (1998) Thyroid controversy - stimulating antibodies. Journal of Clinical Endocrinology and Metabolism, 83, 3777-3785.
14. Zakarija, M., McKenzie, J.M. & Banovac, K. (1980) Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Annals of International Medicine, 93, 28-32.
15. Winsa, B., Rastad, J., Larsson, E., Mandahl, A., Westermark, K., Johansson, H., Juhlin, C., Karlsson, A. & Akerstrom, G. (1994) Total thyroidectomy in therapy-resistant Graves' disease. Surgery, 116, 1068-1074.
16. Patwardhan, N.A., Moroni, M., Rao, S., Rossi, S. & Braverman, L.E. (1993) Surgery still has a role in Graves' hyperthyroidism. Surgey, 114, 1108-1112.
17. Martino, E., Balzano, S., Bartalena, L., Loviselli, A., Ska, V., Petrini, L., Grasso, L., Piga, M. & Braverman, L.E. (1991) Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. Journal of Endocrinology Investigation, 14, 847-851.
18. Braga, M. & Cooper, D.S. (2001) Clinical review 129: Oral cholecystographic agents and the thyroid. Journal of Clinical Endocrinology and Metabolism, 86, 1853-1860.
19. Cooper, D.S. (2000) Treatment of thyrotoxicosis. In: Braverman, L.E. & Utiger, R.D., eds. Werner and Ingbar's The Thyroid. Lippincott Williams & Wilkins, Philadelphia, 691-715.